MEDI-528, now recognized as enokizumab , represents a innovative treatment targeting the IGF-1R , a vital protein involved in several dermatological diseases . Early investigation findings suggest https://elodieipuc565821.pointblog.net/enokizumab-a-deep-dive-into-medi-528-and-its-potential-92673477